chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: skin paresthesia; nerve pain; Extreme fatigue; Chills; Body aches; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 14Apr2021 14:00 (Lot number: Ew0161) at the age of 44 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Hashimoto's thyroiditis" (unspecified if ongoing), notes: Other medical history: Hashimoto's thyroiditis. The patient's concomitant medications were not reported. Past drug history included: Singulair, reaction(s): "Allergy: Singulair". Vaccination history included: Bnt162b2 (Product: COVID 19, Lot unknown: False, Dose number: 1 , dose product: COVID 19, dose brand: Pfizer , dose brand unknown: False, dose lot number: Ep6955, dose lot unknown: False, dose administration time: 01:30 PM, dose vaccine location: Right arm), administration date: 24Mar2021, when the patient was 44 years old, for COVID-19 immunisation. The following information was reported: FATIGUE (non-serious) with onset 15Apr2021 12:00, outcome "recovered" (Apr2021), described as "Extreme fatigue"; CHILLS (non-serious) with onset 15Apr2021 12:00, outcome "recovered" (Apr2021), described as "Chills"; PAIN (non-serious) with onset 15Apr2021 12:00, outcome "recovered" (Apr2021), described as "Body aches"; PARAESTHESIA (non-serious), outcome "unknown", described as "skin paresthesia"; NEURALGIA (non-serious), outcome "unknown", described as "nerve pain". The events "skin paresthesia" and "nerve pain" were evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of fatigue, chills, pain. Therapeutic measures were taken as a result of paraesthesia, neuralgia.  Additional Information: After the first 2 doses I had skin paresthesia/nerve pain So frequently I had to be tested for MS which was negative. There was no other vaccine taken in four weeks. After the booster toradol and steroid shots used as the treatment drug for the event skin paresthesia/nerve pain. hospital type facility vaccine. There was no covid prior vaccine. There was no covid tested post vaccination.  Follow-up attempts are completed. No further information is expected.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: Blurry vision; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51 year-old male patient received bnt162b2 (BNT162B2), administration date 31Mar2021 (Lot number: EP6955) at the age of 51 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Anxiety" (ongoing). Concomitant medication(s) included: CITALOPRAM taken for anxiety; DIAZEPAM. The following information was reported: VISION BLURRED (non-serious) with onset 2021, outcome "recovered" (2021), described as "Blurry vision".  Additional information: He experienced a little bit of blurry vision. He provided her weight as 175-180lbs. He didn't have a prescribing doctor. He got the vaccine trying to be a proactive adult. The blurry vision started about an hour after both shots. The blurry vision is more with his distance vision, even with his glasses on. Which he guess is nearsighted. It was the distance that was effected both times even with glasses on. The blurriness has seemed the same both times. After the first vaccine the blurred vision lasted a week. So he will see what happens with this one. The concomitant medication Diazepam was taken for sleep by patient.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding, Peripheral swelling
Clinical narrative: Swelling on arm right; Blood cots passing; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PERIPHERAL SWELLING (non-serious), outcome "unknown", described as "Swelling on arm right"; HEAVY MENSTRUAL BLEEDING (non-serious), outcome "unknown", described as "Blood cots passing".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Nausea, Pain, Pain in extremity
Clinical narrative: he felt bad; Headache; Nausea; body aches; arm sore where he got the shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 25Apr2021 10:30 (Lot number: EW0167) at the age of 52 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: HEADACHE (non-serious) with onset Apr2021, outcome "not recovered", described as "Headache"; NAUSEA (non-serious) with onset Apr2021, outcome "not recovered", described as "Nausea"; PAIN (non-serious) with onset Apr2021, outcome "not recovered", described as "body aches"; PAIN IN EXTREMITY (non-serious) with onset Apr2021, outcome "not recovered", described as "arm sore where he got the shot"; FEELING ABNORMAL (non-serious), outcome "not recovered", described as "he felt bad". Therapeutic measures were taken as a result of headache, nausea, pain, pain in extremity, feeling abnormal.  Additional Information: The patient stated that he had a headache for a couple days and nausea and body aches which have stayed about the same, they eased up, and came back that morning, it is like he has a hangover or something. He stated that his body aches and his arm was sore where he got the shot. He had been taking Ibuprofen, and the headache and aches was still lingering. Ibuprofen dose unknown. He was thinking that the dose might have been 800, though he had got some 200, he usually takes more, for this he just took one pill. He says he hadn't been to work because he felt bad. He said that his next shot is on 16-May and his first dose was injected 25-Apr at 10:30AM in his left arm.  No follow-up attempts are possible. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Electrocardiogram, Fatigue, Feeling abnormal, Palpitations
Clinical narrative: racing heart/pounding heart; fatigue; feel as bad as I did; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 09Apr2021 12:45 (Batch/Lot number: unknown) at the age of 65 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Bartter Syndrome" (unspecified if ongoing); "previous Broken Synfrome" (unspecified if ongoing); "GERD" (unspecified if ongoing); "Known allergies: Yes" (unspecified if ongoing). Concomitant medication(s) included: SPIRONOLACTONE; TOPROL XL; SLOW MAG [MAGNESIUM CHLORIDE]. Vaccination history included: Bnt162b2 (Product: COVID 19,, brand: Pfizer,, lot unknown: True,, lot unknown reason: Not available/provided to reporter at the time of report completion,, administration date: 19Mar2021,, administration time: 12:00 PM,, dose number: 1,, vaccine location: Left arm), administration date: 19Mar2021, when the patient was 65 years old, for covid-19 immunization, reaction(s): "Racing heart", "severe fatigue". The following information was reported: PALPITATIONS (non-serious) with onset 09Apr2021, outcome "not recovered", described as "racing heart/pounding heart"; FATIGUE (non-serious) with onset 09Apr2021, outcome "not recovered", described as "fatigue"; FEELING ABNORMAL (non-serious) with onset 09Apr2021, outcome "not recovered", described as "feel as bad as I did". The events "racing heart/pounding heart", "fatigue" and "feel as bad as i did" were evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section, which included blood test, ECG and urine analysis, with results: unknown, on an unspecified date. Therapeutic measures were taken as a result of palpitations, fatigue, feeling abnormal.  Additional Information: Second dose caused racing heart and much, much more severe pounding heart and overwhelming fatigue with 2 emergency room visits. Patient was 19 days out from second dose and still feeling deep fatigue and not able to resume normal activities. patient feel as bad as his did within the first week of reactions. No other vaccine was administered in four week by the patient, patient had known allergies, it is unknown If Covid tested post vaccination to the patient.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Urine analysis
Clinical narrative: racing heart/pounding heart; fatigue; feel as bad as I did; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 09Apr2021 12:45 (Batch/Lot number: unknown) at the age of 65 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Bartter Syndrome" (unspecified if ongoing); "previous Broken Synfrome" (unspecified if ongoing); "GERD" (unspecified if ongoing); "Known allergies: Yes" (unspecified if ongoing). Concomitant medication(s) included: SPIRONOLACTONE; TOPROL XL; SLOW MAG [MAGNESIUM CHLORIDE]. Vaccination history included: Bnt162b2 (Product: COVID 19,, brand: Pfizer,, lot unknown: True,, lot unknown reason: Not available/provided to reporter at the time of report completion,, administration date: 19Mar2021,, administration time: 12:00 PM,, dose number: 1,, vaccine location: Left arm), administration date: 19Mar2021, when the patient was 65 years old, for covid-19 immunization, reaction(s): "Racing heart", "severe fatigue". The following information was reported: PALPITATIONS (non-serious) with onset 09Apr2021, outcome "not recovered", described as "racing heart/pounding heart"; FATIGUE (non-serious) with onset 09Apr2021, outcome "not recovered", described as "fatigue"; FEELING ABNORMAL (non-serious) with onset 09Apr2021, outcome "not recovered", described as "feel as bad as I did". The events "racing heart/pounding heart", "fatigue" and "feel as bad as i did" were evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section, which included blood test, ECG and urine analysis, with results: unknown, on an unspecified date. Therapeutic measures were taken as a result of palpitations, fatigue, feeling abnormal.  Additional Information: Second dose caused racing heart and much, much more severe pounding heart and overwhelming fatigue with 2 emergency room visits. Patient was 19 days out from second dose and still feeling deep fatigue and not able to resume normal activities. patient feel as bad as his did within the first week of reactions. No other vaccine was administered in four week by the patient, patient had known allergies, it is unknown If Covid tested post vaccination to the patient.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.    A 80 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 30Mar2021 16:00 (Lot number: EN6207) at the age of 80 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Heart failure" (ongoing), notes: Verbatim: Heart failure, Started about a year ago. Concomitant medication(s) included: SYNTHROID; ENTRESTO taken for cardiac failure; CORLANOR taken for cardiac failure. Vaccination history included: Bnt162b2 (Dose number: 1, Lot number: EN6203), administration date: 04Mar2021, when the patient was 80 years old, for COVID-19 Immunization. The following information was reported: HEADACHE (non-serious) with onset 31Mar2021, outcome "not recovered", described as "Headache". Therapeutic measures were taken as a result of headache.    Additional information: Patient has received both doses of the Pfizer Covid Vaccine. after her first vaccine, she didn't have any side effects. Caller states after her second vaccine, she has had a headache everyday. Caller states she has several heart medications, but she doesn't have her list of medications in front of her. States she is on a blood pressure pill and water pill. About headache, reporter states some days it is worse than others. States it is not severe but moderate. States she takes Tylenol every once in a while. States she doesn't like to take it so much but when it gets really bad, she has to take it. States one day when her headache was worse than others, she took an Excedrin.    No follow-up attempts are possible. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain
Clinical narrative: injection site pain; sore arm; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 31Mar2021 (Lot number: ER8732) at the age of 49 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: FENOFIBRATE; MULTIVITAMINS [VITAMINS NOS]. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "recovered" (2021), described as "injection site pain"; PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "recovered" (2021), described as "sore arm". Therapeutic measures were not taken as a result of vaccination site pain, pain in extremity.  Additional Information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Multi-vitamin and fenofibrate was medications that patient received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had not been tested for COVID-19 since the vaccination. Patient did not visit the emergency room and physician office visit for the events.  No follow-up attempts are possible. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Hypokinesia, Loss of personal independence in daily activities, Muscular weakness
Clinical narrative: patient was not able to do Simple thing like brushing hair; my left arm once again lost strength; I still cannot lift my arm over my head or fully extend my arm outward; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 27 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 21Apr2021 (Lot number: ER8731) at the age of 27 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (product=COVID 19, lot number=ER8733, lot unknown=False, administration date=31Mar2021, dose number=1, vaccine location=Left arm), administration date: 31Mar2021, when the patient was 27 years old, for Covid-19 immunization, reaction(s): "Left size of face went numb", "weakness in left arm". The following information was reported: LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious) with onset Apr2021, outcome "not recovered", described as "patient was not able to do Simple thing like brushing hair"; MUSCULAR WEAKNESS (non-serious) with onset Apr2021, outcome "not recovered", described as "my left arm once again lost strength"; HYPOKINESIA (non-serious) with onset Apr2021, outcome "not recovered", described as "I still cannot lift my arm over my head or fully extend my arm outward". Therapeutic measures were not taken as a result of loss of personal independence in daily activities, muscular weakness, hypokinesia.  Additional information: After second dose (received in right arm) left arm once again lost strength within 1 hour. After 4 days patient still cannot lift arm over head or fully extend arm outward. Simple thing like brushing hair couldn't do with left arm. The patient not had covid prior vaccination. The patient not tested for covid post vaccination. Patient had no known allergies. Patient did not received any other vaccine in four weeks.  No follow-up attempts are possible. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Acne
Clinical narrative: same red bumps/pimples started to form across my forehead and face; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 30 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left (Batch/Lot number: unknown) at the age of 30 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1; Lot number: ER8732, EW0158; Administrator route: Intramuscular, Administration date and time: 02Apr2021and 09:30 AM; vaccine location: Left arm), administration date: 02Apr2021, when the patient was 30 years old, for COVID-19 immunisation, reaction(s): "break out on my forehead. Small red bumps/pimples". The following information was reported: ACNE (non-serious), outcome "recovering", described as "same red bumps/pimples started to form across my forehead and face". Therapeutic measures were not taken as a result of acne.  Additional information: Patient did not experience COVID prior vaccination. Patient didn't test COVID post vaccination. Patient didn't experience any known allergies. Patient did not take other vaccine in four weeks and other medications in two weeks.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain
Clinical narrative: Bad abdominal pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Lot number: Unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2, for COVID-19 immunization. The following information was reported: ABDOMINAL PAIN (non-serious), outcome "unknown", described as "Bad abdominal pain".  Additional information:patient reported receiving both doses of Pfizer Covid-19 Vaccine, after each dose she had experienced bad abdominal pain. She had experienced those abdominal pain now after having that second dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthropathy, Dysstasia, Fall, Feeling abnormal
Clinical narrative: hips are not working; She can't use them; If she tries to get up and stand up, she can't stand up; She is mad because the side effects are so terrible; she fell onto a shelter and she peed; hips are not working; She can't use them; If she tries to get up and stand up, she can't stand up; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 65 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DYSSTASIA (non-serious), ARTHROPATHY (non-serious), outcome "unknown" and all described as "hips are not working; She can't use them; If she tries to get up and stand up, she can't stand up"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "She is mad because the side effects are so terrible"; FALL (non-serious), outcome "unknown", described as "she fell onto a shelter and she urinated".  Additional Information: Reporter stated that she was trying to get to someone. The reason she was reporting is because she had the problems, and she was reporting about side effects. She said that she was reporting about the bad things that have happened to her from having the-she stops her sentence here and says, why aren't you answering me? What are you doing? She was having side effects from the second COVID vaccine. She said, let her try to be nicer. She is mad because the side effects are so terrible. This was probably a strange, strange side effect and she is very smart, and she looks at all the side effects. Why would her hips not work? She can't use them. If she tries to get up and stand up, she can't stand up. Because the day she did the shot she was 100% normal, then she went to sleep and woke up at 11:00 PM at night and couldn't get her hips out to go pee and she could barely get there. She thinks there was no other difference in her life other than when they did the shot. She like scrambled across the end of the bed and then she fell onto a shelter, and she peed and then she had to walk back to the bedroom, and she couldn't even hardly roll over to get into the bed. Why else would somebody else make her body do that? There was nothing that she wanted other than she wanted to be able to roll over and go to the bathroom. Reporter seriousness for the events were unspecified.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: injection site swelling after her first dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 12Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "spinal cord disorder" (unspecified if ongoing); "breast cancer" (unspecified if ongoing), notes: survivor for 33 years; "Anxiety" (unspecified if ongoing); "Muscle Pain" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION SITE SWELLING (non-serious), outcome "unknown", described as "injection site swelling after her first dose".  Additional information: she also experienced injection site swelling after her first dose. She is taking pain medication, anxiety medication, blood pressure and blood thinner. She is also a breast cancer survivor for 33 years.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Lethargy, Vaccination site pain
Clinical narrative: Arm hurt/back of left arm where got the shot of first vaccine; Lethargic/first vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 25Mar2021, outcome "recovered" (Mar2021), described as "Arm hurt/back of left arm where got the shot of first vaccine"; LETHARGY (non-serious) with onset 25Mar2021, outcome "recovered" (2021), described as "Lethargic/first vaccine".  Additional information: The reporter stated that his left arm, where he got the shot, on the second day hurt(25Mar2021), also mentioned that he had pain in his arm after the first vaccine, but that was to be expected. He was lethargic after both vaccines, under his left elbow, there was a sharp pain for 5 days, that was not killing him, but was persistent, still present and not going away. He stated that everyone told him that his arm was uncomfortable, and felt off for a couple of days, after the vaccine. Everyone he knows, his age or older, said the same thing. No further details were provided by him. The patient history and other product information was not provided.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Influenza
Clinical narrative: Flu; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INFLUENZA (non-serious), outcome "unknown", described as "Flu".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: I just had those two shots you take and I am not exhausted and not feeling real well or chipper today; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 72 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 72 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose1), for COVID-19 Immunisation. The following information was reported: MALAISE (non-serious), outcome "unknown", described as "I just had those two shots you take and I am not exhausted and not feeling real well or chipper today".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Pain
Clinical narrative: All I've felt is a little fatigued; little aches pains; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 02Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "All I've felt is a little fatigued"; PAIN (non-serious), outcome "unknown", described as "little aches pains". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Patient received second dose of Pfizer vaccine on 4-2-21. Patient wife wasn't able to get the vaccine yet as she became very sick and then tested covid positive on 4-20-21. Patient has been with her almost 24 hours a day and even sleep in the same bed. Patient felt was little fatigued and a little aches pains. Patient has taken two tests, and both are negative.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Ear discomfort, Head discomfort
Clinical narrative: She became dizzy; Her ears are bothering her; Her head doesn't feel right; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 19Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious) with onset Apr2021, outcome "recovered" (Apr2021), described as "She became dizzy"; EAR DISCOMFORT (non-serious) with onset Apr2021, outcome "unknown", described as "Her ears are bothering her"; HEAD DISCOMFORT (non-serious) with onset Apr2021, outcome "unknown", described as "Her head doesn't feel right".  Additional information: Patent received the 1st dose of the vaccine on 19Apr2021 but on Saturday she became dizzy and her ears are bothering her. Today (at the time of report) she was not as dizzy anymore but her head doesn't feel right.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Back disorder
Clinical narrative: back problem; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 06Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: BACK DISORDER (non-serious), outcome "unknown", described as "back problem".  Additional information: Patient has a back problem and he wanted to ask if he can take the tablet or the medicine before taking the second dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Road traffic accident
Clinical narrative: she's scheduled for the 2nd dose today, 18Apr2021, and she's unable to take it because she had a car accident today; This is a spontaneous report received from a contactable reporter (Consumer) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 28Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ROAD TRAFFIC ACCIDENT (non-serious) with onset 18Apr2021, outcome "unknown", described as "she's scheduled for the 2nd dose today, 18Apr2021, and she's unable to take it because she had a car accident today". Additional Information: The patient was scheduled for the 2nd dose today, 18Apr2021, and she's unable to take it because she had a car accident today. She got the 1st dose on 28Mar2021, and she's asking if it would still be ok to take the 2nd dose anytime this week since it will be more than 3 weeks when she got the 1st dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Vaccination site pain
Clinical narrative: this morning she presented pain on her right breast; she presented severe pain in the injection site, it hurts from her elbow to shoulder; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (005570). The reporter is the patient.  A 59 year-old female patient received bnt162b2 (BNT162B2), administration date 28Apr2021 (Batch/Lot number: unknown) at the age of 59 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 28Apr2021, outcome "unknown", described as "she presented severe pain in the injection site, it hurts from her elbow to shoulder"; BREAST PAIN (non-serious) with onset 29Apr2021, outcome "unknown", described as "this morning she presented pain on her right breast".  Additional information: the patient stated that after receiving the first dose of the Pfizer Covid-19 vaccine yesterday she presented severe pain in the injection site, it hurts from her elbow to shoulder and this morning she presented pain on her right breast. She would like to know if the pain is normal.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: Arm became mobile again; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 84 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 21Jan2021 09:45 (Lot number: EL3249, Expiration Date: May2021) at the age of 84 years as dose 1, single and administered in arm right, administration date 12Feb2021 09:00 (Lot number: EL9266, Expiration Date: May2021) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Poliomyelitis" (unspecified if ongoing), notes: Verbatim: Polio, Had polio at 9 years old. Due to having polio, she only has 30% of kidney access. When she had polio, it took out one kidney so she only has a partial kidney left; "damaged her right arm" (unspecified if ongoing), notes: She had damaged her right arm in lifting heavy objects during November and December. She could not raise that arm above her head and she was afraid she damaged her rotator cuff. She was upset about that. The patient took concomitant medications. The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious) with onset 22Jan2021, outcome "unknown", described as "Arm became mobile again".  Additional information: When she went to get the first shot in Jan, the physician asked which arm did she want it in and she decided to get it in her right arm because she could hardly move it anyway. Within 24 hours of getting the vaccine, her arm was mobile again and she has had no problems since. Whether she had damaged muscles and the vaccine relaxed the muscles or what, she has no way of knowing, but the doctor's and three nurses said she should report this good thing to Pfizer. She's 84 years old and she had polio when she was 9. She was really upset about her shoulder because she couldn't even lift her arm to brush her hair, it was that bad. She was very happy with her COVID shot.   No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal chest pain
Clinical narrative: getting a lot of pain on his lower rib at the back and on the side; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 23Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MUSCULOSKELETAL CHEST PAIN (non-serious), outcome "unknown", described as "getting a lot of pain on his lower rib at the back and on the side".  Additional information: It was reported as, they were called in because he got the 1st dose of the vaccine on 23Apr2021 and he said he was getting a lot of pain on his lower rib at the back and on the side. He wants to know if it was a side effect of the vaccine and if there were reported side effects like this after getting the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Rash macular
Clinical narrative: red spots/on arms and legs; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 78 year-old female patient received bnt162b2 (BNT162B2), administration date Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: RASH MACULAR (non-serious) with onset Apr2021, outcome "unknown", described as "red spots/on arms and legs". Additional information: Patient had Pfizer Covid first dose "a week and a half ago" but did not remember the exact date. Then had red spots that she didn't have before, on arms and legs and she started to experience it this week (did not specify the date).   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Malaise
Clinical narrative: today she has a little bit of a headache; Not feeling well; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 62 year-old female patient received bnt162b2 (BNT162B2), administration date 08Apr2021 (Batch/Lot number: unknown) as dose 1,single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious) with onset 29Apr2021, outcome "unknown", described as "today she has a little bit of a headache"; MALAISE (non-serious) with onset 29Apr2021, outcome "unknown", described as "Not feeling well". Therapeutic measures were taken as a result of headache, malaise.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm soreness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.   A 40 year-old female patient received bnt162b2 (BNT162B2), administration date 15Apr2021 10:30 (Batch/Lot number: unknown) at the age of 40 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 15Apr2021 12:00, outcome "unknown", described as "arm soreness".  Additional information: They made an appointment to receive the first dose of the vaccine on 15Apr2021 at 1030 am. They waited the 15 minutes at the vaccination facility and they had no reaction they were sent home with a factsheet for side effects to look out for and to take Tylenol if needed. The reporter stated that when they got home around 12 pm his daughter had arm soreness.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Dyspepsia
Clinical narrative: metallic taste; heartburn; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 42 year-old female patient received bnt162b2 (BNT162B2), administration date 19Apr2021 (Batch/Lot number: unknown) at the age of 42 years as dose 1, single and (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DYSGEUSIA (non-serious), outcome "unknown", described as "metallic taste"; DYSPEPSIA (non-serious), outcome "unknown", described as "heartburn".  Additional Information: Patient had metallic taste on her mouth for 3 days and a half after the first dose and after the second dose she experienced a stronger metallic taste that lasted a day and heartburn  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Dark circles under eyes
Clinical narrative: dark underneath both eyes; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 76 year-old male patient received bnt162b2 (BNT162B2), administered in deltoid left, administration date 25Jan2021 09:00 (Lot number: EX3246) at the age of 76 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (He has been received 1st dose., Lot Number: EX3246, 1st shot: 04Jan2021 09:05 AM, ER visit), administration date: 04Jan2021, when the patient was 76 years old, for Covid-19 immunisation, reaction(s): "right side of my face and eyes are closing up", "left upper shoulder, it was little sore", "my face was itching", "my face begin to come up like pink like buff red rash like on it/ rash come up on my face and I felt like some heat bumps on my face and I was itching", "My eyes puffed up", "my face and eyelid swollen up a little bit, my eye lids the top of my eye lids", "my face and eyelid swollen up a little bit, my eye lids the top of my eye lids", "cold and hot". The following information was reported: DARK CIRCLES UNDER EYES (non-serious) with onset 22Feb2021, outcome "unknown", described as "dark underneath both eyes".  Additional information: Patient was still experiencing the adverse events due to dose 1. patient reported his top Eyelid was swallowed with his back of head toward in the middle of shoulders to see. so he had too drive too the ER. Himself and 15-yr-old daughter with him. Shots through IV. No surgery planned prior to taking the product.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Feeling abnormal, Lymphadenopathy
Clinical narrative: swollen lymphnodes; stomach discomfort; felt so bad the day after; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 24Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose1 manufacturer unknown.), for Covid-19 immunization. The following information was reported: LYMPHADENOPATHY (non-serious), outcome "unknown", described as "swollen lymphnodes"; ABDOMINAL DISCOMFORT (non-serious), outcome "unknown", described as "stomach discomfort"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "felt so bad the day after". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache
Clinical narrative: slight headache; minor cold chills; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A 49 year-old female patient received bnt162b2 (BNT162B2), administration date 25Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, Single), administration date: 28Mar2021, for COVID-19 immunization. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "slight headache"; CHILLS (non-serious), outcome "unknown", described as "minor cold chills".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Oropharyngeal pain, Rhinorrhoea
Clinical narrative: feeling sick; sore throat; runny nose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: MALAISE (non-serious), outcome "unknown", described as "feeling sick"; OROPHARYNGEAL PAIN (non-serious), outcome "unknown", described as "sore throat"; RHINORRHOEA (non-serious), outcome "unknown", described as "runny nose". Therapeutic measures were taken as a result of malaise, oropharyngeal pain, rhinorrhoea.  Additional Information: Age of patient: 52, unknown unit. The patient was feeling sick and she has second covid shot tomorrow. The consumer asked if it is ok if she gets it. She doesn't think it is Covid because she only has a sore throat and runny nose. She was on an antibiotic, asked if that will be an issue.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: I had a really bad reaction/week after got very sick; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 80 year-old female patient received bnt162b2 (BNT162B2), administration date 03Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Steroids. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "I had a really bad reaction/week after got very sick".  Additional information: The patient got first Pfizer vaccine on 03FEB, week after got very sick, saw hematologist and rheumatologist, still not out of problem, still on steroids. Patient was recommended not to get the shot at all or for a while.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Injection site extravasation
Clinical narrative: Felt liquid going down the back of his arm and wrist; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team.  A male patient received bnt162b2 (BNT162B2), administration date 22Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First Dose), for COVID-19 Immunization. The following information was reported: INJECTION SITE EXTRAVASATION (non-serious) with onset 22Apr2021, outcome "unknown", described as "Felt liquid going down the back of his arm and wrist".  Additional information: Pharmacist states that she had a patient who received the second dose of the Covid vaccine on 22Apr2021, in which the patient states he felt liquid going down the back of his arm and wrist. Caller believes the vaccine may have came through the hub, in which they were unsure of how much vaccine was lost.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.